Abstract
The familial hypercholesterolemia (FH) is an inherited autosomal dominant disorder that predisposes premature development of cardiovascular diseases, such as atherosclerosis, myocardial infarction and coronary disease. The clinic phenotype starts to develop in heterozygous patients (HeFH) at fourth decade of life in men and at fifth in women. Homozygous patients (HoFH) presents cardiovasc…